首页 | 本学科首页   官方微博 | 高级检索  
     


MERTK mutation update in inherited retinal diseases
Authors:Isabelle Audo  Saddek Mohand‐Said  Elise Boulanger‐Scemama  Xavier Zanlonghi  Christel Condroyer  Vanessa Démontant  Fiona Boyard  Aline Antonio  Cécile Méjécase  Said El Shamieh  José‐Alain Sahel  Christina Zeitz
Affiliation:1. Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France;2. CHNO des Quinze‐Vingts, DHU Sight Restore, Paris, France;3. University College London Institute of Ophthalmology, London, UK;4. Fondation Ophtalmologique Adolphe de Rothschild, Paris, France;5. Clinique Pluridisciplinaire Jules Verne, Nantes, France;6. Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon;7. Académie des Sciences‐Institut de France, Paris, France;8. Department of Ophthalmology, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania
Abstract:MER tyrosine kinase (MERTK) encodes a surface receptor localized at the apical membrane of the retinal pigment epithelium. It plays a critical role in photoreceptor outer segment internalization prior to phagocytosis. Mutations in MERTK have been associated with severe autosomal recessive retinal dystrophies in the RCS rat and in humans. We present here a comprehensive review of all reported MERTK disease causing variants with the associated phenotype. In addition, we provide further data and insights of a large cohort of 1,195 inherited retinal dystrophies (IRD) index cases applying state‐of‐the‐art genotyping techniques and summarize current knowledge. A total of 79 variants have now been identified underlying rod‐cone dystrophy and cone‐rod dystrophy including 11 novel variants reported here. The mutation spectrum in MERTK includes 33 missense, 12 nonsense, 12 splice defects, 12 small deletions, 2 small insertion–deletions, 3 small duplications, and 2 exonic and 3 gross deletions. Altogether, mutations in MERTK account for ~2% of IRD cases with a severe retinal phenotype. These data are important for current and future therapeutic trials including gene replacement therapy or cell‐based therapy.
Keywords:inherited retinal dystrophy  MERTK  mutation spectrum  mutation prevalence
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号